Browse
Search
BOH minutes 111815
OrangeCountyNC
>
Advisory Boards and Commissions - Active
>
Board of Health
>
Minutes
>
2015
>
BOH minutes 111815
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
3/22/2018 3:07:23 PM
Creation date
3/5/2018 4:04:15 PM
Metadata
Fields
Template:
BOCC
Date
11/18/2015
Meeting Type
Regular Meeting
Document Type
Advisory Bd. Minutes
Document Relationships
BOH agenda 111815
(Attachment)
Path:
\Advisory Boards and Commissions - Active\Board of Health\Agendas\2015
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
7
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
MINUTES-Final <br />ORANGE COUNTY BOARD OF HEALTH <br />November 18, 2015 <br />S:\Managers Working Files\BOH\Agenda & Abstracts\2016 Agenda & Abstracts/ January Page 6 <br /> <br />Ms. Bridges provided information on 3 kinds of LARCs – Nexplanon subdermal implant, Mirena <br />IUD and Paraguard IUD. Their effectiveness ranged from a maximum of 3 years up to a <br />maximum of 10-12 years. The associated costs (device and procedure) varied as well. In <br />2014-2015, 12% of women in the OCHD Family Planning Program were using LARCS with <br />Nexplanon having the greatest use by our clients followed by the 2 IUDs Mirena and Paraguard, <br />respectively. In the U.S., 7.2% of women ages 15-44 used LARCs. The Colorado Family <br />Planning Initiative increased LARC use in Title X clinics from 4.5% in 2008 to 19.4% in 2011. <br />The OCHD’s goal is to meet and/or exceed Colorado’s 19.4%. <br /> <br />She continued by stating that some possible barriers to LARCs were concerns regarding <br />procedure and side effects as well as others’ negative experiences. Cost was also a barrier as <br />59% of LARCs users were self-pay. Of that 59%, 84% of that group actually slid to 0% having to <br />pay nothing. Ms. Bridges also noted some of the best practices for increasing LARC use which <br />included offering LARCs first, leading with its benefits, exploring and incorporating patient <br />preferences and reducing barriers such as cost and the number of appointments. The <br />recommendation to the BOH was to: <br /> <br />• Move forward with high and moderate impact, low difficulty best practices <br />- Exam room visuals; educational pamphlets, electronic promotion/outreach <br />- Provider tip-sharing opportunities and staff education <br />• Support initiatives for high impact, moderate-high difficulty best practices <br />- Consider video clip use and evaluate against organizational priorities <br />- Support work toward identification of contraceptive tool at intake <br /> <br />The BOH members had questions that were addressed by Ms. Bridges and Dr. Bridger. <br /> <br />B. Radon Action Month <br /> <br />The NC Department of Health and Human Services Division of Health Service Regulation <br />Radiation Protection Section has asked that the BOH recognize January as National Radon <br />Month. Alan Clapp, Environmental Health Director, provided information on Radon Action <br />Month as the OCHD is partnering with the NC Radon program to provide free short-term radon <br />test kits in recognition of National Radon Action Month. A limited supply of 100 test kits for <br />Orange County will be available from January 11th through January 29th. They will be distributed <br />by Environmental Health. <br /> <br />Motion to pass the resolution to recognize January 2016 as Radon Action Month in <br />Orange County was made by Sam Lasris, seconded by Barbara Chavious and carried <br />without dissent. <br /> <br />The BOH members had questions that were addressed by Mr. Clapp. <br /> <br />C. Media Items <br /> <br />Media items were in the packet which focused on Orange County’s events and our <br />involvement in various efforts. <br /> <br />VIII. Closed Session to Discuss Health Director’s Annual Review <br />
The URL can be used to link to this page
Your browser does not support the video tag.